Form D · Other Technology
Orgio, Inc.
New York, NY · CIK 0001782617
Offering snapshot reported Sep 18, 2024 · SEC filing
- Reported sold
- $1.99M Offering amount: $1.99M
- Investors reported
- 15 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 20, 2024 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Sep 18, 2024 | Initial | $1,991,192 | No comparison | 15 | SEC filing |
| Sep 28, 2021 | Initial | $19,999,977 | No comparison | 15 | SEC filing |
| Feb 21, 2020 | Initial | $8,499,989 | No comparison | 21 | SEC filing |
| Jul 18, 2019 | Initial | $2,716,292 | No comparison | 13 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-524380
Total Amount Sold includes the conversion of SAFEs (Simple Agreement for Future Equity).
Offer and sale of Series Seed Preferred Stock and Common Stock issuable upon conversion thereof.
Source: Form D, filed Sep 18, 2024. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Martin Hauge | Director |
| Andreas Jarbol | Director, Executive |
| Keith Rabois | Director |
| Christian Wylonis | Director, Executive |
Issuer details
Industry: Other Technology (See others in industry)
Address:
222 Broadway, 22nd Floor
New York, NY, 10038
New York, NY, 10038